Discover 1,437 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,437
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
for
Asthma
Location: San Antonio TX, Shreveport LA, Oklahoma City OK,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12+
Code: NCT07456033
Phase 3, Recruiting
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
for
Narcolepsy Type 1, Narcolepsy Type 2
Location: San Antonio TX, Austin TX, Sugar Land TX, Houston TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All
Age: 18 - 70
Code: NCT07598708
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
for
Narcolepsy Type 1
Location: San Antonio TX, Sugar Land TX, Dallas TX, Frisco TX,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07540897
Phase 3, Recruiting
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
for
Ulcerative Colitis (UC)
Location: San Antonio TX, Cedar Park TX, Georgetown TX,
Sponsor: Xencor, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06619990
Phase 1, Phase 2, Recruiting
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: San Antonio TX, Fort Worth TX, Westwood KS,
Sponsor: Corcept Therapeutics
Sex: All
Age: 18+
Code: NCT07259317
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
for
Neoplasms
Location: San Antonio TX, Chicago IL, West Valley City UT,
Sponsor: Corcept Therapeutics
Sex: All
Age: 18+
Code: NCT07276373
Phase 1, Phase 2, Recruiting
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors